Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: cytomegalovirus pp65-specific cytotoxic T lymphocytes|GENETIC: polymerase chain reaction|OTHER: diagnostic laboratory biomarker analysis|OTHER: flow cytometry|OTHER: immunologic technique
Sponsor: University of Louisville
Collaborators: Penn State University